AQX-1125
AQX-1125 is the company's most advanced product and is being developed for the treatment of cancer and inflammatory disease. It has many desirable drug attributes that make it especially compelling:
- it is highly selective
- it is a small molecule (<500 daltons)
- it is water soluble
- it is easily synthesized
- it is orally bioavailable
- it has shown potent anti-inflammatory activity both in vitro and in vivo
